Search by Drug Name or NDC

    NDC 65862-0942-03 LEVALBUTEROL 1.25 mg/.5mL Details

    LEVALBUTEROL 1.25 mg/.5mL

    LEVALBUTEROL is a RESPIRATORY (INHALATION) SOLUTION, CONCENTRATE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is LEVALBUTEROL HYDROCHLORIDE.

    Product Information

    NDC 65862-0942
    Product ID 65862-942_08fe55b3-a3cd-d8cf-e063-6394a90a1a95
    Associated GPIs 44201045102560
    GCN Sequence Number 057879
    GCN Sequence Number Description levalbuterol HCl VIAL-NEB 1.25MG/0.5 INHALATION
    HIC3 B6W
    HIC3 Description BETA-ADRENERGIC AGENTS, INHALED, SHORT ACTING
    GCN 23146
    HICL Sequence Number 019858
    HICL Sequence Number Description LEVALBUTEROL HCL
    Brand/Generic Generic
    Proprietary Name LEVALBUTEROL
    Proprietary Name Suffix n/a
    Non-Proprietary Name LEVALBUTEROL
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION, CONCENTRATE
    Route RESPIRATORY (INHALATION)
    Active Ingredient Strength 1.25
    Active Ingredient Units mg/.5mL
    Substance Name LEVALBUTEROL HYDROCHLORIDE
    Labeler Name Aurobindo Pharma Limited
    Pharmaceutical Class Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA207628
    Listing Certified Through 2024-12-31

    Package

    NDC 65862-0942-03 (65862094203)

    NDC Package Code 65862-942-03
    Billing NDC 65862094203
    Package 30 POUCH in 1 CARTON (65862-942-03) / 1 VIAL, SINGLE-DOSE in 1 POUCH (65862-942-50) / .5 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2017-01-31
    NDC Exclude Flag N
    Pricing Information N/A